₹ 136.4
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Parmax Pharma Limited primarily manufactures active pharmaceutical ingredients (APIs), including ampicillin, amoxicillin, cephalexin, and nalidixic acid. The company also intends to expand its activities into the formulation of finished dosage forms such as tablets, capsules, ointments, and injectables. Established on November 2, 1994, the firm's corporate headquarters are located in Rajkot, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Data is available to registered users only